Elon Musk's Neuralink relocates its corporate from Delaware to Nevada

Musk says Neuralink had successfully implanted its first brain chip in a human patient, who was recovering well post-procedure
A representational image of a brain. — Unsplash

A representational image of a brain. — Unsplash

Neuralink, Elon Musk's brain-chip implant company, has shifted its location of incorporation from Delaware to Nevada, according to the business portals of both states.

This move follows Musk's recent announcement that Tesla plans to hold a shareholder vote to transfer its state of incorporation from Delaware to Texas, prompted by a judge's invalidation of his $56 billion pay package.

However, transitioning Tesla's state of incorporation may encounter obstacles, including potential lawsuits from investors, especially if perceived as a plan to secure his pay package, legal experts said.

Musk said last week that Neuralink had successfully implanted its first brain chip in a human patient, who was recovering well post-procedure.

Read more: Neuralink implants first chip on human brain — Musk

When reached for comment, Neuralink did not immediately respond to Reuters' request.

According to Gadgets360, in September 2023, Neuralink obtained approval from an independent review board to commence recruitment for its first human trial involving a brain implant designed for paralysis patients.

The trial is open to individuals with paralysis stemming from cervical spinal cord injury or amyotrophic lateral sclerosis, although specific enrollment figures were not disclosed. The trial is anticipated to span approximately six years.

The study will use a robot to surgically put a brain-computer interface (BCI) implant in a brain region that controls the meaning to move, Neuralink said, adding that its primary goal is to facilitate people to control a computer cursor or keyboard using their thoughts alone.